Home LiteratureArticle Details
PMID: 1534364 Published · ppublish English Clinical Trial Comparative Study Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Effect of viral respiratory tract infection on outcome of acute otitis media.

The Journal of pediatrics ·Vol. 120 ·No. 6 ·1992-06-00 ·Pages 856-62

Chonmaitree T, Owen MJ, Patel JA, Hedgpeth D, Horlick D, Howie VM

Abstract

We prospectively studied 271 infants and children (2 months to 7 years of age) with acute otitis media (AOM) for viral and bacterial causes, outcome at the end of therapy, and frequency of recurrence within 1 month. Comprehensive virologic methods, including viral antigen detection, cell culture, and serologic studies, were used to diagnose viral infection of the respiratory tract, middle ear, or both. Evidence of viral infection was found in 46% (124/271) of patients with AOM. Sixty-six patients (24%) had virus or viral antigen in the middle ear fluid; 50 of these patients (76%) also had bacteria in middle ear fluid, and 16 (24%) had virus alone. More patients with AOM and combined bacterial and viral infection (51%) had persistent otitis (3 to 12 days after institution of antibiotic treatment), compared with those with only bacterial otitis (35%; p = 0.05) or patients with only viral infection (19%; p less than 0.01). Of patients with only viral infection, 4 of 10 with virus in middle ear fluid had persistent otitis, compared with none of 11 patients who had virus only in nasal wash specimens or whose viral infection was diagnosed only by serologic studies. Our data suggest that viruses interact with bacteria and that concurrent viral infection can significantly worsen the clinical course of bacterial AOM. The presence of virus in middle ear fluid may contribute to the pathogenesis and outcome of bacterial AOM. The mechanism of these interactions deserve further investigation.

MeSH Terms
Amoxicillin/therapeutic use Amoxicillin-Potassium Clavulanate Combination Bacterial Infections/drug therapy,epidemiology Ceftizoxime/analogs & derivatives,therapeutic use Clarithromycin Clavulanic Acids/therapeutic use Drug Therapy, Combination/therapeutic use Erythromycin/analogs & derivatives,therapeutic use Female Humans Infant Male Otitis Media/drug therapy,epidemiology,microbiology Respiratory Tract Infections/epidemiology Treatment Outcome Virus Diseases/epidemiology
Chemicals
Clavulanic Acids Erythromycin Amoxicillin-Potassium Clavulanate Combination cefpodoxime Amoxicillin Ceftizoxime Clarithromycin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Chonmaitree T
Department of Pediatrics, University of Texas Medical Branch, Galveston 77550.
Owen M J
Patel J A
Hedgpeth D
Horlick D
Howie V M
Article Info
Journal
The Journal of pediatrics
Abbr.
J Pediatr
ISSN
0022-3476
Published
1992-06-00
Pages
856-62
Language
English
Region
United States
NLM ID
0375410
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com